Caitong International Asset Management Co., LTD Voyager Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 445 shares of VYGR stock, worth $1,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
445Holding current value
$1,464% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VYGR
# of Institutions
122Shares Held
34.3MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$17.9 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$17.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$12.9 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.46 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $127M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...